aTYR PHARMA INC financial data

Symbol
ATYR on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 608% % -3.2%
Return On Equity -100% % -26%
Return On Assets -75% % -26%
Operating Margin -41395% % -43%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97,986,634 shares 17%
Common Stock, Shares, Outstanding 97,986,634 shares 29%
Entity Public Float $116,242,729 USD -3.8%
Common Stock, Value, Issued $98,000 USD 29%
Weighted Average Number of Shares Outstanding, Basic 97,153,541 shares 28%
Weighted Average Number of Shares Outstanding, Diluted 97,153,541 shares 28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $190,000 USD -19%
Research and Development Expense $61,556,000 USD 12%
General and Administrative Expense $17,285,000 USD 29%
Operating Income (Loss) $78,651,000 USD -16%
Nonoperating Income (Expense) $3,524,000 USD -17%
Net Income (Loss) Attributable to Parent $75,122,000 USD -18%
Earnings Per Share, Basic 0 USD/shares 11%
Earnings Per Share, Diluted 0 USD/shares 11%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,150,000 USD -46%
Assets, Current $93,014,000 USD 22%
Property, Plant and Equipment, Net $4,429,000 USD -12%
Operating Lease, Right-of-Use Asset $5,603,000 USD -4.7%
Other Assets, Noncurrent $149,000 USD 15%
Assets $106,652,000 USD 16%
Accounts Payable, Current $4,064,000 USD 2.9%
Employee-related Liabilities, Current $3,093,000 USD 14%
Accrued Liabilities, Current $10,185,000 USD 14%
Liabilities, Current $15,678,000 USD 11%
Operating Lease, Liability, Noncurrent $10,532,000 USD -7.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,000 USD -103%
Retained Earnings (Accumulated Deficit) $592,201,000 USD -15%
Stockholders' Equity Attributable to Parent $80,235,000 USD 23%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $80,044,000 USD 23%
Liabilities and Equity $106,652,000 USD 16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $15,420,000 USD 31%
Net Cash Provided by (Used in) Financing Activities $18,628,000 USD 141%
Net Cash Provided by (Used in) Investing Activities $4,420,000 USD -226%
Common Stock, Shares Authorized 170,000,000 shares 0%
Common Stock, Shares, Issued 97,986,634 shares 29%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,212,000 USD 92%
Interest Paid, Excluding Capitalized Interest, Operating Activities $28,000 USD -26%
Deferred Tax Assets, Valuation Allowance $124,183,000 USD 15%
Deferred Tax Assets, Gross $125,406,000 USD 15%
Operating Lease, Liability $11,331,000 USD -5.7%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $75,159,000 USD -18%
Property, Plant and Equipment, Gross $9,392,000 USD -7.5%
Operating Lease, Liability, Current $799,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,916,000 USD 7.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,780,000 USD 3.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,637,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,975,000 USD 3.1%
Deferred Tax Assets, Operating Loss Carryforwards $68,799,000 USD 14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $36,757,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,975,000 USD 1.7%
Additional Paid in Capital $672,339,000 USD 15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $167,000 USD -6.2%
Deferred Tax Assets, Net of Valuation Allowance $1,223,000 USD -14%
Share-based Payment Arrangement, Expense $4,560,000 USD 58%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%